0001047469-15-004272 Sample Contracts

FACILITIES AND SERVICE AGREEMENT

Facilities and Service Agreement • May 1st, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales

• Contract Type
  Facilities and Service Agreement
• Filed
  May 1st, 2015
• Company
  Adaptimmune Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  England and Wales

Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 and

Assignment and Exclusive Licence • May 1st, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales

• Contract Type
  Assignment and Exclusive Licence
• Filed
  May 1st, 2015
• Company
  Adaptimmune Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  England and Wales

SUB-LICENSE AGREEMENT Between ADAPTIMMUNE LIMITED (as licensee) And LIFE TECHNOLOGIES CORPORATION (as licensor)

Sub-License Agreement • May 1st, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances)

• Contract Type
  Sub-License Agreement
• Filed
  May 1st, 2015
• Company
  Adaptimmune Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)

This Exclusive License (hereinafter called “LICENSE”) is made and entered into by and among the United States Department of the Navy at the Naval Medical Research Center (hereinafter called “NAVY”), the Regents of the University of Michigan (hereinafter called “UM”), Dana Farber Cancer Institute, Inc. (hereinafter call “DFCI”) and Invitrogen Corporation, a Delaware corporation (hereinafter called “LICENSEE”) whose headquarters are located at 5791 Van Allen Way, Carlsbad, CA 92008. Each of NAVY, UM, DFCI and LICENSEE is a “PARTY” hereunder, and may be collectively referred to as the “PARTIES”. Each of the NAVY, UM and DFCI is a LICENSOR hereunder, and may be collectively referred to as the LICENSORS.